Studies have demonstrated the efficacy of statin therapy, with on-treatment levels of Apo A1 and Apo B identified as significant predictors of myocardial infarction and all-cause mortality in patients with established coronary artery disease, suggesting their potential in assessing cardiovascular risk [5]. This evidence concerns the gene APOB and coronary artery disorder.